Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Tennant, A. Tarver, R. Rawson (1984)
Clinical evaluation of mecamylamine for withdrawal from nicotine dependence.NIDA research monograph, 49
Domino Ef (1983)
Neuropsychopharmacology of nicotine and tobacco smoking.Psychopharmacology Bulletin, 19
L. Seyler, O. Pomerleau, J. Fertig, Dorothy Hunt, K. Parker (1986)
Pituitary hormone response to cigarette smokingPharmacology Biochemistry and Behavior, 24
(1980)
Ganglionic stimulating and blocking agents
R. Spealman, S. Goldberg (1982)
Maintenance of schedule-controlled behavior by intravenous injections of nicotine in squirrel monkeys.The Journal of pharmacology and experimental therapeutics, 223 2
Dr. Stolerman, T. Goldfarb, R. Fink, M. Jarvik (2004)
Influencing cigarette smoking with nicotine antagonistsPsychopharmacologia, 28
J. Henningfield (1984)
Pharmacologic basis and treatment of cigarette smoking.The Journal of clinical psychiatry, 45 12 Pt 2
R. Herning, Reese Jones, N. Benowitz, A. Mines (1983)
How a cigarette is smoked determines blood nicotine levelsClinical Pharmacology & Therapeutics, 33
B. Barrass, J. Blackburn, R. Brimblecombe, P. Rich (1969)
Modification of nicotine toxicity by pretreatment with different drugs.Biochemical pharmacology, 18 9
(1973)
Further observations on nicotine as the reinforcing agent in smoking
(1973)
Further observations on nicotine as the reinforcing agent in smoking. In: Dunn WL (ed) Smoking behavior: motives and incentives
O. Pomerleau, J. Fertig, Sandra Shanahan (1983)
Nocotine dependence in cigarette smoking: An empirically-based, multivariate modelPharmacology Biochemistry and Behavior, 19
R. Nemeth-Coslett, J. Henningfield, M. O'Keeffe, R. Griffiths (2004)
Effects of mecamylamine on human cigarette smoking and subjective ratingsPsychopharmacology, 88
S. Goldberg, R. Spealman, M. Risner, J. Henningfield (1983)
Control of behavior by intravenous nicotine injections in laboratory animalsPharmacology Biochemistry and Behavior, 19
A. Atkinson, A. Littman (1981)
The pharmacological basis of therapeutics. 6th ed: By Alfred Goodman Gilman, Louis S. Goodman, and Alfred Gilman. 1843 pp., $45.00. Macmillan Publishing Co., Inc., New York, New York, 1980Gastroenterology, 80
O. Pomerleau, Dennis Turk, J. Fertig (1984)
The effects of cigarette smoking on pain and anxiety.Addictive behaviors, 9 3
213 91 91 3 3 C. S. Pomerleau O. F. Pomerleau M. J. Majchrzak Behavioral Medicine Program, Department of Psychiatry University of Michigan 48105 Ann Arbor MI USA Abstract Acute administration of mecamylamine, a centrally active nicotinic cholinergic agonist, has been shown to increase amount of smoking as indicated by smoking topography (e.g., puff rate, puff duration), expired carbon monoxide changes, and other inferential measures. In the present study, subjects showed significantly greater increases in plasma nicotine following smoking of two high-nicotine research cigarettes when pretreated with mecamylamine than when pretreated with placebo, even though no significant differences in puff volume or puff number were detected. Interestingly, none of our subjects reported nausea, although some achieved plasma nicotine levels at which nausea would typically be expected. We attribute the observed increases in nicotine intake to compensatory behavior designed to overcome mecamylamine's blocking effects.
Psychopharmacology – Springer Journals
Published: Sep 1, 1987
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.